12.07.2015 Views

Issues Paper - South Western Sydney Local Health District - NSW ...

Issues Paper - South Western Sydney Local Health District - NSW ...

Issues Paper - South Western Sydney Local Health District - NSW ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

A Research Strategy for <strong>South</strong> <strong>Western</strong> <strong>Sydney</strong> <strong>Local</strong> <strong>Health</strong> <strong>District</strong> – <strong>Paper</strong> No.1 <strong>Issues</strong> Final April 2012studies) in areas such as COPD, paediatrics, cancer, obstetrics and gynaecology andorthopaedics.The recent appointment of a part-time Clinical Trials director (and statistician mentionedabove) through the Ingham Institute are important actions to strengthen trial leadership anddirection in clinical trials. However while clinicians and researchers have the capability toexpand trials, the historical gaps in coordination and lack of core infrastructure havehampered this work and require urgent attention. While some of these problems arecommon to all researchers, some are specific to clinical trials. In addition to the dearth ofbiostatistical expertise, randomisation services are outsourced; clinical trial pharmacists (andstaff and systems for drug invoicing) are unavailable or funded on an adhoc basis; there areno standard operating procedures to manage risk and inform proper practice; andindemnity arrangements do not align with community care arrangements. Induction andmandatory training in Good Clinical Practice (GCP) consistent with the InternationalConference on Harmonisation (ICH) is also not available and mentorship is adhoc.The <strong>South</strong> <strong>Western</strong> Area Pathology Service (SWAPS) provides pathology services to researchon a cost recovery basis (where appropriate). Although the proposed amalgamation of all<strong>NSW</strong> pathology services into a single <strong>NSW</strong> entity may support the strategic development ofresearch pathology services. However currently SWAPS has variable capacity, space andequipment to significantly increase its support to research and research pathologyarrangements (including cost recovery) require review and updating. An added concern isthe lack of research specific policies and systems in tissue sampling, management (includingdispatch), cataloguing and long term storage of research samples.Clinical trials nurses/coordinators face additional barriers with difficulty in gaining approval(and funding) to attend mandatory training, trial meetings and conferences; inadequatesalaries associated with inflexible award application; and “red tape” in ensuring practicalsupport to patients e.g. free on-site parking.Specific issues identified in Ethics governance include delays in processing ethicsapplications which have resulted in the loss of pharmaceutical industry funding, the lack ofclinical trial pharmacy expertise on the Ethics Committee and in site specific assessments;and the increasing workload associated with adverse event reporting requirements.The potential to undertake health services research, using clinical trials methodology, in areassuch as aged care, community care and mental health where the range of models ofservice are expanding are prime areas of research growth and development.Summary of issuesStatistics and pharmacy are unavailable or funded on an ad hoc basisThere are a range of clinical trial policy and processes which require development.This includes research pathology systems and processesClinical trials assistants have difficulty undertaking standard parts of their rolerequirements such as travel to investigator meetingsEthics governance has caused severe delays resulting in the loss of pharmaceuticalindustry sponsored trials.SWSLHD| 15

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!